Targeted delivery of nanoparticles for in vivo CAR T therapy
Strike Pharma AB is a pioneering force in biotechnology research, dedicated to advancing innovative therapies for significant medical needs. With a focus on targeted nanoparticle delivery, Strike Pharma is revolutionizing in vivo CAR-T therapy, offering cutting-edge solutions for autoimmune diseases and B-cell lymphomas.
Located at Ulls väg 29c in Uppsala, Strike Pharma leverages its proprietary technology to develop groundbreaking treatments. The company's lead candidate, STR3/19, utilizes a lipid nanoparticle to deliver mRNA for an anti-CD19 CAR selectively to T cells, providing an off-the-shelf alternative to traditional CAR-T therapies. This innovative approach reprograms T cells to B-cell depleting CAR-Ts within the body, showcasing Strike Pharma's commitment to personalized medicine and immunotherapy.
Strike Pharma AB is committed to shaping the future of biotechnology. We invite the management team at Strike Pharma AB to further enhance your company's profile by creating a customized and exclusive company showcase and product listing on our platform, ensuring maximum visibility and commercial success.
Compare Strike Pharma AB with 3 companies in Biotechnology-Research
| Comparison Field |
Strike Pharma ABMain Company |
Im
ImmPACT BioView Profile |
MaxCyte, Inc.View Profile |
Advanced Therapies,...View Profile |
|---|---|---|---|---|
|
Founded Year
|
— | 2017 | 1999 | 2004 |
|
Company Size
|
— | 51-200 | 51-200 | 501-1,000 |
|
City
|
West Hills, California | Rockville, Maryland | Philadelphia, Pennsylvania | |
|
Country
|
United States | United States | ||
|
Skills & Keywords
Comparing with main company
|
10 Total Skills
Biotechnology
Nanoparticle Delivery
CAR-T Therapy
Immunotherapy
Personalized Medicine
Drug Development
B-cell Lymphoma
Personalized medicine
Immuno-oncology
CAR-T
|
8 Total
8 Unique
Unique Skills:
autoimmune
Cancer Therapy
Logic gate
lupus
On target off tumor toxicity
Oncology
+2
|
18 Total
18 Unique
Unique Skills:
Bispecifics
Cancer
Cancer Research
CARMA
Cell Engineering
Cell Therapy
+12
|
30 Total
30 Unique
Unique Skills:
AAV
Adventitious Agent Testing
Allogeneic
Analytical Development
Antibody Drug Conjugate
Autologous
+24
|
Other organizations in the same industry
This company is also known as